| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-07 |